We are live on
!
Find out more
Denali Therapeutics
DNLI
DNLI
58 hedge funds and large institutions have $1.2B invested in Denali Therapeutics in 2018 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
87% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 15
75% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 8
32% more capital invested
Capital invested by funds: $909M → $1.2B (+$291M)
29% more funds holding
Funds holding: 45 → 58 (+13)
0.12% more ownership
Funds ownership: 64.56% → 64.69% (+0.12%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
58
Holders Change
+13
Holders Change %
+28.89%
% of All Funds
1.33%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
28
Increased
14
Reduced
8
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
+$21.7M |
| 2 |
BAMCO Inc
New York
|
+$8.71M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$7.64M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$5.85M |
| 5 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$5.57M |
Top Sellers
| 1 |
Norges Bank
Oslo,
Norway
|
-$7.9M |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$1.85M |
| 3 |
FCMI
Foresite Capital Management IV
Larkspur,
California
|
-$1.48M |
| 4 |
Millennium Management
New York
|
-$1.48M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
-$1.07M |
